Interleukin 6 inhibits HBV entry through NTCP down regulation

Virology

Volumn 481, Issue , 2015, Pages 34-42

  Bouezzedine, Fidaa ^a,b,c   Fardel, Olivier ^a,b,c   Gripon, Philippe ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Cytokines; HepaRG; Hepatitis B virus; Hepatocytes; IL 6; Inflammation; NTCP; Viral entry

Indexed keywords

COMPLEMENTARY DNA; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 6; MESSENGER RNA; SODIUM BILE ACID COTRANSPORTER; TAUROCHOLIC ACID; VIRUS DNA; COTRANSPORTER; ORGANIC ANION TRANSPORTER; SODIUM-BILE ACID COTRANSPORTER; VIRUS RECEPTOR;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; BILE ACID METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG TARGETING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MICROBIAL KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; STEADY STATE; VIRUS ENTRY; VIRUS INHIBITION; GENETICS; HEPG2 CELL LINE; METABOLISM; PHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS;

DOWN-REGULATION; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; INTERLEUKIN-6; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; RECEPTORS, VIRUS; SYMPORTERS; VIRUS INTERNALIZATION;

EID: 84924326333     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.02.026     Document Type: Article

References (42)

1. Cressman D.E., Diamond R.H., Taub R. Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology 1995, 21:1443-1449.
2. Fisicaro P., Valdatta C., Boni C., Massari M., Mori C., Zerbini A., Orlandini A., Sacchelli L., Missale G., Ferrari C. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 2009, 58:974-982. 10.1136/gut.2008.163600.
3. Geier A., Wagner M., Dietrich C.G., Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim. Biophys. Acta 2007, 1773:283-308. 10.1016/j.bbamcr.2006.04.014.
4. Gripon P., Cannie I., Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 2005, 79:1613-1622. 10.1128/JVI.79.3.1613-1622.2005.
5. Gripon P., Diot C., Guguen-Guillouzo C. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 1993, 192:534-540. 10.1006/viro.1993.1069.
6. Gripon P., Diot C., Thézé N., Fourel I., Loreal O., Brechot C., Guguen-Guillouzo C., Theze N. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 1988, 62:4136-4143.
7. Gripon P., Le Seyec J., Rumin S., Guguen-Guillouzo C. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 1995, 213:292-299. 10.1006/viro.1995.0002.
8. Gripon P., Rumin S., Urban S., Le Seyec J., Glaise D., Cannie I., Guyomard C., Lucas J., Trepo C., Guguen-Guillouzo C. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 2002, 99:15655-15660. 10.1073/pnas.232137699.
9. Hösel M., Quasdorff M., Wiegmann K., Webb D., Zedler U., Broxtermann M., Tedjokusumo R., Esser K., Arzberger S., Kirschning C.J., Langenkamp A., Falk C., Büning H., Rose-John S., Protzer U. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 2009, 50:1773-1782. 10.1002/hep.23226.
10. Jung D., Hagenbuch B., Fried M., Meier P.J., Kullak-Ublick G.a. Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:G752-G761. 10.1152/ajpgi.00456.2003.
11. Kim J.H., Lee S., Li L., Park H., Park J., Lee K.Y., Kim M., Shin B.A., Choi S. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 2011, 6(4):e18556. 10.1371/journal.pone.0018556.
12. Kishida D., Okuda Y., Onishi M., Takebayashi M., Matoba K., Jouyama K., Yamada A., Sawada N., Mokuda S., Takasugi K. Successful tocilizumab treatment in a patient with adult-onset Still[U+05F3]s disease complicated by chronic active hepatitis B and amyloid A amyloidosis. Mod. Rheumatol. 2011, 21:215-218. 10.1007/s10165-010-0365-8.
13. Klein M., Thomas M., Hofmann U., Seehofer D., Damm G., Zanger U.M. A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells. Drug Metab. Dispos. 2015, 43:273-283. doi:10.1124.
14. Kuo T.-M., Hu C.-P., Chen Y.-L., Hong M.-H., Jeng K.-S., Liang C.-C.T., Chen M.-L., Chang C. HBV replication is significantly reduced by IL-6. J. Biomed. Sci. 2009, 16:41. 10.1186/1423-0127-16-41.
15. Le Seyec J., Chouteau P., Cannie I., Guguen-Guillouzo C., Gripon P. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 1998, 72:5573-5578.
16. Le Seyec J., Chouteau P., Cannie I., Guguen-Guillouzo C., Gripon P. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J. Virol. 1999, 73:2052-2057.
17. Le Vee M., Gripon P., Stieger B., Fardel O. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab. Dispos. 2008, 36:217-222. 10.1124/dmd.107.016907.
18. Le Vee M., Jigorel E., Glaise D., Gripon P., Guguen-Guillouzo C., Fardel O. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci 2006, 28:109-117. 10.1016/j.ejps.2006.01.004.
19. Le Vee M., Jouan E., Stieger B. Regulation of drug transporter expression by oncostatin M in human hepatocytes. Biochem. Pharmacol. 2011, 82:304-311. 10.1016/j.bcp.2011.04.017.
20. Le Vee M., Lecureur V., Moreau A., Stieger B., Fardel O. Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes. Drug Metab. Dispos. 2009, 37:2228-2235. doi:dmd.109.028035 [pii]\r10.1124/dmd.109.028035.
21. Le Vee M., Stieger B., Fardel O., Le Vee M., Lecureur V., Stieger B., Fardel O. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab. Dispos. 2009, 37:685-693. 10.1124/dmd.108.023630.
22. Lepère-Douard C., Trotard M., Le Seyec J., Gripon P. The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity. J. Virol. 2009, 83:11819-11829. 10.1128/JVI.01026-09.
23. Lucifora J., Xia Y., Reisinger F., Zhang K., Stadler D., Cheng X., Sprinzl M.F., Koppensteiner H., Makowska Z., Volz T., Remouchamps C., Chou W.-M., Thasler W.E., Hüser N., Durantel D., Liang T.J., Münk C., Heim M.H., Browning J.L., Dejardin E., Dandri M., Schindler M., Heikenwalder M., Protzer U. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 2014, 343:1221-1228. 10.1126/science.1243462.
24. Macovei A., Radulescu C., Lazar C., Petrescu S., Durantel D., Dwek R.A., Zitzmann N., Nichita N.B. Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. J. Virol. 2010, 84:243-253. 10.1128/JVI.01207-09.
25. Maeng C.Y., Ryu C.J., Gripon P., Guguen-Guillouzo C., Hong H.J. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1. Virology 2000, 270:9-16. 10.1006/viro.2000.0250.
26. Nègre D., Mangeot P.E., Duisit G., Blanchard S., Vidalain P.O., Leissner P., Winter A.J., Rabourdin-Combe C., Mehtali M., Moullier P., Darlix J.L., Cosset F.L. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther. 2000, 7:1613-1623. 10.1038/sj.gt.3301292.
27. Noel G., Le Vee M., Moreau A., Stieger B., Parmentier Y., Fardel O. Functional expression and regulation of drug transporters in monolayer- and sandwich-cultured mouse hepatocytes. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 2013, 49:39-50. 10.1016/j.ejps.2013.01.013.
28. Pan C.J.-H., Wu H.-L., Kuo S.F.-T., Kao J.-H., Tseng T.-C., Liu C.-H., Chen P.-J., Liu C.-J., Chen D.-S. Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B. Hepatol. Int., 2012, 6:591-597. 10.1007/s12072-011-9299-2.
29. Schulze A., Gripon P., Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 2007, 46:1759-1768. 10.1002/hep.21896.
30. Schulze A., Mills K., Weiss T.S., Urban S. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 2012, 55:373-383. 10.1002/hep.24707.
31. Seeger C., Mason W. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 2000, 64:51-68.
32. Sekiyama K.D., Yoshiba M., Thomson A.W. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin. Exp. Immunol. 1994, 98:71-77.
33. Stacey A.R., Norris P.J., Qin L., Haygreen E.a, Taylor E., Heitman J., Lebedeva M., DeCamp A., Li D., Grove D., Self S.G., Borrow P. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 2009, 83:3719-3733. 10.1128/JVI.01844-08.
34. Sun Y., Tokushige K., Isono E., Yamauchi K., Obata H. Elevated serum interleukin-6 levels in patients with acute hepatitis. J. Clin. Immunol. 1992, 12:197-200.
35. Tiberio G.A.M., Tiberio L., Benetti A., Cervi E., Montani N., Dreano M., Garotta G., Cerea K., Steimberg N., Pandolfo G., Ferrari-Bravo A., Mazzoleni G., Giulini S.M., Schiaffonati L. IL-6 Promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy. Cytokine 2008, 42:372-378. 10.1016/j.cyto.2008.03.012.
36. Torre D., Zeroli C., Giola M., Ferrario G., Fiori G.P., Bonetta G., Tambini R. Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 1994, 18:194-198.
37. Urban S., Bartenschlager R., Kubitz R., Zoulim F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology 2014, 147:48-64. 10.1053/j.gastro.2014.04.030.
38. Watashi K., Liang G., Iwamoto M., Marusawa H., Uchida N., Daito T., Kitamura K., Muramatsu M., Ohashi H., Kiyohara T., Suzuki R., Li J., Tong S., Tanaka Y., Murata K., Aizaki H., Wakita T. Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID). J. Biol. Chem. 2013, 288:31715-31727. 10.1074/jbc.M113.501122.
39. Werle-Lapostolle B., Bowden S., Locarnini S., Wursthorn K., Petersen J., Lau G., Trepo C., Marcellin P., Goodman Z., Delaney W.E. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004, 126:1750-1758. 10.1053/j.gastro.2004.03.018.
40. Wieland S.F., Chisari F.V. Stealth and cunning: hepatitis B and hepatitis C viruses. J. Virol. 2005, 79:9369-9380. 10.1128/JVI.79.15.9369-9380.2005.
41. Wu H.-L., Kao J.-H., Chen T.-C., Wu W.-H., Liu C.-H., Su T.-H., Yang H.-C., Chen D.-S., Chen P.-J., Liu C.-J. Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications. J. Gastroenterol. Hepatol. 2014, 29:1629-1636. 10.1111/jgh.12606.
42. Yan H., Zhong G., Xu G., He W., Jing Z., Gao Z., Huang Y., Qi Y., Peng B., Wang H., Fu L., Song M., Chen P., Gao W., Ren B., Sun Y., Cai T., Feng X., Sui J., Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012, 1:e00049. 10.7554/eLife.00049.